Key Takeaways
- Corebridge added a Nasdaq-100 strategy and an S&P 500 High Bonus strategy to Max Accumulator+ III on June 29, bringing the total index crediting options to five, but neither the press release nor the product filing disclosed current cap rates or participation rates for the new strategies.
- The Nasdaq-100 crediting option is unavailable in California and New York, two of the largest IUL markets in the country. Corebridge gave no public explanation.
- If you are being shown an illustration on the updated Max Accumulator+ III, ask to see both the projected column and the guaranteed column side by side. Under the AG49-A consumer-protection disclosures that took effect July 1, 2026, carriers are now required to provide additional context, but the guaranteed column is still the only contractual floor, and that number almost always tells a different story than the projected.
- Corebridge is in a pending merger with Equitable Holdings, with Marc Costantini set to lead the combined company as CEO. Product launches and enhancements timed ahead of a merger deserve extra scrutiny. Distribution agreements and illustration software updates may shift after the deal closes.
- If an agent is pitching you this product primarily on the Nasdaq-100 upside, ask what the floor is on that strategy and what happens to your death benefit if the policy underperforms for five consecutive years. Compare that scenario against a 20-year level-term policy at current rates before committing.
Corebridge Financial (NYSE: CRBG) announced on June 29, 2026 that it has enhanced its Max Accumulator+ III indexed universal life insurance product, adding two new index crediting strategies and making what the company described as “structural improvements intended to strengthen long-term accumulation.” The new options are a Nasdaq-100 strategy and an S&P 500 High Bonus strategy, bringing the product’s total index crediting menu to five. The announcement arrived four days before the NAIC’s updated AG49-A consumer-protection disclosure requirements took effect on July 1.
That timing matters. The gap between what Corebridge announced and what buyers need to know before signing is wide enough to drive a policy lapse through.
What the Press Release Says, and What It Doesn’t
The June 29 BusinessWire release describes the Nasdaq-100 strategy as providing “exposure to technology and growth-oriented companies” and the S&P 500 High Bonus strategy as featuring “a bonus feature designed to support accumulation in varying market conditions.” The release says the updates “incorporate structural improvements intended to strengthen long-term accumulation” compared to prior product versions.
Nothing in the public announcement discloses the current cap rate or participation rate on either new strategy. That is the number that drives the illustration. Without it, the phrase “enhanced growth potential” is marketing copy, not a product specification.
Corebridge issued the policies through American General Life Insurance Company in Houston. Except in New York, where the issuer is The United States Life Insurance Company in the City of New York. The Nasdaq-100 strategy is unavailable in California and New York. No explanation was offered for the California exclusion. California’s CDI (California Department of Insurance) has a prior-approval process for life insurance forms, and any state-specific form filing for the Nasdaq-100 option would be subject to CDI review before it could be offered there. The CDI has not publicly announced any pending filing action related to this product update.
The S&P 500 High Bonus strategy deserves particular attention. IUL products with bonus crediting features were a primary target of the 2023 AG49-A revision, which tightened illustration limits on accounts that use bonuses and multipliers linked to an index. The concern regulators had, and still have, is that bonus features can make an illustration look substantially better than the policy will actually perform. Under the 2023 revision to AG49-A and the 2026 consumer-protection disclosure enhancements that took effect this week, illustration actuaries are required to cap the illustrated leverage on bonus accounts so they do not illustrate better than a plain-vanilla benchmark index account.
Corebridge’s press release does not specify whether the S&P 500 High Bonus strategy’s illustrated rate will be constrained by those AG49-A limits or whether the “bonus feature” operates outside the parameters the 2023 revision targeted. The answer would be in the product’s illustration software and the accompanying actuary certification. Neither of which is public.
The Illustration Question You Should Ask Before Signing
I’ve sat through a lot of IUL illustration reviews. The number most agents lead with is the projected column: what the policy accumulates if the current cap and participation rate hold, credited annually at the maximum AG49-A-permitted illustrated rate. That column is what the software calculates under current NAIC-permitted assumptions. It looks good. It almost always looks good.
The guaranteed column is something else entirely. It shows what the policy is contractually required to deliver under worst-case assumptions: minimum crediting rates, maximum cost of insurance charges, and no bonuses. Run the same Max Accumulator+ III illustration at guaranteed assumptions and compare the projected cash value at year 20 to the guaranteed cash value at year 20. On most accumulation-focused IUL products, that gap is not cosmetic. The MIB Group database and prescription pharmacy database will surface health conditions the applicant didn’t disclose, but they won’t surface the fact that a product’s cap rate has been reduced three times since the illustration was run.
Here is the specific question to ask: “Show me the guaranteed column, and then show me what happens to the death benefit and cash value if the cap rate on the Nasdaq-100 strategy is reduced by 200 basis points two years into the policy.” A good agent will run that scenario without hesitation. An agent who can’t or won’t run it is giving you the product, not the information.
For buyers who are comparing this against term, the math is worth doing first. A healthy 35-year-old purchasing a 20-year, $500,000 level-term policy through a preferred-plus carrier pays roughly $22 to $28 per month at today’s rates. An IUL policy designed to deliver similar death benefit coverage with a cash accumulation component will require substantially higher premiums to fund the insurance charge and the index account at a level that makes the illustration meaningful. The difference funds either a policy that may or may not perform, or a brokerage account you control directly. Compare both options against your actual goals before an agent runs only one illustration. Our guide to best life insurance and best term life insurance cover that comparison in more detail.
Corebridge also noted that some Max Accumulator+ III policies may qualify for Agile Underwriting+, its accelerated underwriting process that skips the medical exam, lab work, and attending physician statement. Accelerated underwriting sounds like a consumer benefit, and in some cases it is. But it also means the MIB database and prescription history pull do more of the work that a paramed exam would otherwise surface. Applicants with borderline health histories who qualify for accelerated underwriting on a no-exam basis may find a rating action or rescission if undisclosed conditions emerge later. The standard underwriting paper trail is also consumer protection, not just a hurdle.
One piece of context the press release buries: Corebridge is in a pending merger with Equitable Holdings. According to Investing.com, Marc Costantini will lead the combined company as CEO, with Equitable’s Mark Pearson serving as executive chair. Product enhancements timed close to a merger close warrant scrutiny. Cap rates on IUL crediting strategies are not locked in at issue. Carriers can and do reduce them over time, and distribution agreements, illustration software contracts, and product maintenance priorities can all shift post-merger. Existing Max Accumulator+ III policyholders should note their current credited rates and request an in-force illustration annually regardless of what any agent tells them about illustrated performance.
The NAIC’s AG49-A consumer-protection disclosures that took effect July 1, 2026 require carriers to provide enhanced context in illustrations, but they do not require an agent to walk through the guaranteed column proactively. That conversation still has to come from the buyer.
